3 more blood pressure drugs recalled over cancer concern
A generic drug company has recalled three commonly prescribed blood pressure medications over concerns they could include small amounts of a cancer-causing impurity.
The recalled drugs all include the blood-pressure medication valsartan, the subject of a series of recalls by several drug companies since July.
Mylan Pharmaceuticals recalled 104 lots of three medications: valsartan tablets, combination tablets with the drugs valsartan and amlodipine, and combination tablets with valsartan and hydrochlorothiazide.
Tests revealed that valsartan contained trace amounts of a possible human carcinogen, the company said.
Mylan said patients should consult their doctor or pharmacist before stopping their current medication.